| Enhancing oral vaccine potency by targeting intestinal M cells A Azizi, A Kumar, F Diaz-Mitoma, J Mestecky PLoS pathogens 6 (11), e1001147, 2010 | 205 | 2010 |
| Transient expression and purification of chimeric heavy chain antibodies J Zhang, X Liu, A Bell, R To, TN Baral, A Azizi, J Li, B Cass, Y Durocher Protein Expression and Purification 65 (1), 77-82, 2009 | 126 | 2009 |
| Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2 T Naas, M Ghorbani, I Alvarez-Maya, M Lapner, R Kothary, ... Journal of General Virology 86 (8), 2185-2196, 2005 | 93 | 2005 |
| Innovative bioinformatic approaches for developing peptide‐based vaccines against hypervariable viruses D Sirskyj, F Diaz‐Mitoma, A Golshani, A Kumar, A Azizi Immunology and Cell Biology 89 (1), 81-89, 2011 | 88 | 2011 |
| Chemical-genetic profile analysis of five inhibitory compounds in yeast M Alamgir, V Erukova, M Jessulat, A Azizi, A Golshani BMC chemical biology 10, 1-15, 2010 | 74 | 2010 |
| Advances and challenges in mucosal adjuvant technology D Newsted, F Fallahi, A Golshani, A Azizi Vaccine 33 (21), 2399-2405, 2015 | 68 | 2015 |
| Mucosal HIV vaccines: a holy grail or a dud? A Azizi, H Ghunaim, F Diaz-Mitoma, J Mestecky Vaccine 28 (24), 4015-4026, 2010 | 44 | 2010 |
| A global investigation of gene deletion strains that affect premature stop codon bypass in yeast, Saccharomyces cerevisiae B Samanfar, K Shostak, F Chalabian, Z Wu, M Alamgir, N Sunba, ... Molecular Biosystems 10 (4), 916-924, 2014 | 36 | 2014 |
| Induction of broad cross-subtype-specific HIV-1 immune responses by a novel multivalent HIV-1 peptide vaccine in cynomolgus macaques A Azizi, DE Anderson, JV Torres, A Ogrel, M Ghorbani, C Soare, ... The Journal of Immunology 180 (4), 2174-2186, 2008 | 35 | 2008 |
| Viral peptide immunogens: current challenges and opportunities A Azizi, F Diaz‐Mitoma Journal of Peptide Science: An Official Publication of the European Peptide …, 2007 | 34 | 2007 |
| A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses A Azizi, S Aucoin, H Tadesse, R Frost, M Ghorbani, C Soare, T Naas, ... Genetic Vaccines and Therapy 3, 1-10, 2005 | 22 | 2005 |
| Comparison of antibody-and cell-mediated immune responses after intramuscular hepatitis C immunizations of BALB/c mice M Ghorbani, T Nass, A Azizi, C Soare, S Aucoin, A Giulivi, DE Anderson, ... Viral Immunology 18 (4), 637-648, 2005 | 21 | 2005 |
| Preliminary evaluation of next-generation sequencing performance relative to qPCR and in vitro cell culture tests for human cytomegalovirus SHS Ng, A Azizi, K Edamura, RJ Malott, RL Charlebois, C Logvinoff, ... PDA Journal of Pharmaceutical Science and Technology 68 (6), 563-571, 2014 | 14 | 2014 |
| Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters A Azizi, DE Anderson, M Ghorbani, K Gee, F Diaz-Mitoma BMC immunology 7, 1-11, 2006 | 14 | 2006 |
| New approaches for characterization of the genetic stability of vaccine cell lines S Ng, L Gisonni-Lex, A Azizi Human vaccines & immunotherapeutics 13 (7), 1669-1672, 2017 | 13 | 2017 |
| Potency of cell-mediated immune responses to different combined HIV-1 immunogens in a humanized murine model A Azizi, M Ghorbani, M Kryworuchko, S Aucoin, F Diaz-Mitoma Human Vaccines 1 (4), 170-176, 2005 | 12 | 2005 |
| Mechanisms Underlying the Immune Response Generated by an Oral Vibrio cholerae Vaccine D Sirskyj, A Kumar, A Azizi International journal of molecular sciences 17 (7), 1062, 2016 | 10 | 2016 |
| Detection of influenza A and B neutralizing antibodies in vaccinated ferrets and macaques using specific biotin–streptavidin conjugated antibodies D Sirskyj, R Weltzin, A Golshani, D Anderson, J Bozic, F Diaz-Mitoma, ... Journal of virological methods 163 (2), 459-464, 2010 | 9 | 2010 |
| Evaluation of infectious titer in a candidate HSV type 2 vaccine by a quantitative molecular approach A Azizi, M Tang, L Gisonni-Lex, L Mallet BMC microbiology 13, 1-7, 2013 | 8 | 2013 |
| Synergistic effect of combined HIV/HCV immunogens: a combined HIV-1/HCV candidate vaccine induces a higher level of CD8+ T cell-immune responses in HLA-A2. 1 mice A Azizi, M Ghorbani, C Soare, M Mojibian, F Diaz-Mitoma Current HIV Research 5 (2), 211-219, 2007 | 8 | 2007 |
